MedPath

UNIVERSITY OF ALABAMA AT BIRMINGHAM

🇺🇸United States
Ownership
-
Established
1969-01-01
Employees
2K
Market Cap
-
Website
http://www.uab.edu

Study of Nintedanib Plus Bevacizumab in Advanced Solid Tumors

Phase 1
Completed
Conditions
Renal Cell Carcinoma
Colorectal Adenocarcinoma
Non-squamous Non-small Cell Lung Cancer
Platinum-refractory Ovarian Carcinoma
Cervical Carcinoma
Interventions
First Posted Date
2016-07-18
Last Posted Date
2018-07-10
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
21
Registration Number
NCT02835833
Locations
🇺🇸

University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States

Effects of Diet on Brain Processing

Not Applicable
Completed
Conditions
HIV
Neurocognitive Impairment
Interventions
Dietary Supplement: Ketogenic Diet
First Posted Date
2016-07-18
Last Posted Date
2019-12-16
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
17
Registration Number
NCT02835820
Locations
🇺🇸

UAB 1917 Clinic, Birmingham, Alabama, United States

Late Permissive Hypercapnia for Intubated and Ventilated Preterm Infants

Not Applicable
Completed
Conditions
Premature Neonate
Interventions
Other: Higher permissive hypercapnia
Other: Lower Permissive Hypercapnia
First Posted Date
2016-06-15
Last Posted Date
2021-05-03
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
130
Registration Number
NCT02799875
Locations
🇺🇸

UAB, Birmingham, Alabama, United States

Treatment Outcomes of ReACT for PNES

Not Applicable
Completed
Conditions
Convulsion, Non-Epileptic
Interventions
Behavioral: ReACT
Behavioral: Supportive Therapy
First Posted Date
2016-06-15
Last Posted Date
2022-03-07
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
94
Registration Number
NCT02801136
Locations
🇺🇸

Sparks Center Office of Psychiatric Research, Birmingham, Alabama, United States

Environmental or Nasal Cannula Oxygen for Preterm Infants Receiving Oxygen Therapy: a Randomized Cross-over Pilot Study

Not Applicable
Completed
Conditions
Infant, Newborn, Diseases
Hypoxia
Interventions
Procedure: Nasal Cannula Oxygen
Procedure: Oxygen Environment
First Posted Date
2016-06-09
Last Posted Date
2016-12-01
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
25
Registration Number
NCT02794662
Locations
🇺🇸

University of Alabama at Birmingham, Birmingham, Alabama, United States

Virtual Gout Clinic

Not Applicable
Completed
Conditions
Gout
Interventions
Behavioral: Pharmacist-Led Intervention
First Posted Date
2016-06-03
Last Posted Date
2019-11-12
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
1463
Registration Number
NCT02790463
Locations
🇺🇸

University of Alabama at Birmingham, Birmingham, Alabama, United States

🇺🇸

Kaiser Permanente, Pasadena, California, United States

A Carbohydrate-restricted Diet to Reverse Fatty Liver in Adolescents With Obesity

Not Applicable
Completed
Conditions
Non-alcoholic Fatty Liver Disease
Insulin Resistance
Childhood Obesity
Interventions
Other: Carbohydrate-restricted diet
Other: Control, low-fat diet
First Posted Date
2016-06-01
Last Posted Date
2022-02-21
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
27
Registration Number
NCT02787668
Locations
🇺🇸

University of Alabama at Birmingham, Birmingham, Alabama, United States

Machines Assisting Recovery From Stroke

Not Applicable
Completed
Conditions
Cerebrovascular Disease; Sequelae
Interventions
Other: Factor Targeted Walking Training
Device: treadmill
First Posted Date
2016-06-01
Last Posted Date
2019-04-02
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
22
Registration Number
NCT02787694
Locations
🇺🇸

Locomotor Control Lab, Birmingham, Alabama, United States

Falls-based Training for Walking Post-Stroke

Not Applicable
Completed
Conditions
Cerebral Hemiplegia
Interventions
Other: Hands-Free Walking
Other: Challenge Based plus Hands-Free'
First Posted Date
2016-06-01
Last Posted Date
2018-02-26
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
54
Registration Number
NCT02787759

Treatment of Macrophage Activation Syndrome (MAS) With Anakinra

Phase 1
Terminated
Conditions
Macrophage Activation Syndrome
Interventions
Drug: placebo
Drug: kineret
First Posted Date
2016-05-23
Last Posted Date
2024-08-01
Lead Sponsor
University of Alabama at Birmingham
Target Recruit Count
9
Registration Number
NCT02780583
Locations
🇺🇸

University of Alabama at Birmingham, Birmingham, Alabama, United States

© Copyright 2025. All Rights Reserved by MedPath